Why CRWV Stock dropped -9.66% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, CoreWeave Inc. scores 24 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." Across the five pillars, the fundamental cash engine scores 5 of 20 (ROIC -0.2%; FCF yield -18%), indicating the business is not currently converting capital into positive returns or free cash flow. The whale 13F flow pillar scores 7 of 20 (institutional accumulation and options positioning), the insider conviction pillar scores 6 of 20 (SEC Form 4 and Congressional PTR cluster flow), the macro regime fit pillar scores 3 of 20 (beta 1.4; sector sensitivity), and the forensic balance sheet pillar scores 3 of 20 (Altman Z 0.45; Piotroski F 4/9; Debt/Equity 4.4).

For a prospective investor evaluating the stock on 2026-11-02, the pillar pattern points to weak internal cash generation and a stretched balance sheet as the dominant concerns. The forensic readings (Altman Z 0.45, Piotroski F 4/9, Debt/Equity 4.4) are the kind of metrics analysts use to frame financial distress risk, and the macro pillar indicates above-market sensitivity to market swings. Upside drivers implied by the data are limited to the sentiment and flow signals in the 13F and insider pillars, which score higher than the fundamental pillars but still well below the midpoint. Valuation tradeoffs are visible in the market data: the forward P/E is 19 while trailing EPS is -2.12 and free cash flow yield is -18%, so the stock's valuation depends heavily on earnings expectations that the trailing financials do not yet show. This analysis is educational and not personalized financial advice.

CoreWeave Inc. is a NASDAQ-listed issuer classified under the Technology sector and the Computer Software: Prepackaged Software industry, per the company profile. The source data does not describe its specific products, customers, or revenue model. The reported revenue growth from $229.0M in FY 2023 to $5131.0M in FY 2025 is shown in the SEC financials, but the source data does not specify how these revenues are generated.

Per the SEC financials, net income was negative in all three periods, and free cash flow was negative in FY 2025 and FY 2024. Per the market data, gross margin is 71.7%, operating margin is -0.9%, and net margin is -22.8%. ROIC is -0.2%. Per the Roarable RQD rating, the Altman Z-Score is 0.45, the Piotroski F-Score is 4/9, and Debt/Equity is 4.4, which together describe a balance sheet under substantial financial pressure. Debt rose from $4311.5M in FY 2023 to $14665.0M in FY 2025.

Per the recent news and catalysts section, the headlines are dominated by market-action coverage. A green-flagged catalyst reports a Goldman Sachs upgrade to Buy with the stock attempting a rebound (1h ago). Red-flagged risk-watch items include a CNBC piece on the AI trade (3h ago), a report that CoreWeave and IREN fell to 2026 lows as Nebius dropped 7% (12h ago), and a Yahoo Finance report that a prominent Wall Street bear has become more bearish (15h ago). A Motley Fool piece suggesting a possible move to $100 and a Barchart item referencing a November 10 date are flagged yellow as market-wire items. The butterfly supply-chain graph shows no supply-chain links and no proprietary signals, so no graph-derived catalysts are available.

Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals. The source data therefore does not identify upstream suppliers, downstream customers, or sector correlation pathways. The only sector-level ripple visible in the news wire is the headline linking CoreWeave's 2026 low to a drop in Nebius and IREN, which suggests peer co-movement among AI-infrastructure names, but the source data does not quantify this correlation. Investors should watch for peer-driven selloffs as a second-order risk given the beta of 1.4.

• What specific products and customers generate the $5131.0M of FY 2025 revenue, and how much of it is contracted versus spot-based?
• What is the path from negative free cash flow of $-7251.0M in FY 2025 to positive cash generation, and what capital expenditure assumptions underlie it?
• How is the $14665.0M debt load scheduled, and what refinancing or covenant exposures exist?
• What analyst consensus, price targets, and institutional or insider holdings apply, given that the analyst and holders sources are empty?
• What is the basis for the Goldman Sachs upgrade headline, and does it reflect a change in the fundamental outlook?